| Year |
Citation |
Score |
| 2020 |
Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, et al. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. Jama Dermatology. PMID 32725204 DOI: 10.1001/Jamadermatol.2020.1729 |
0.306 |
|
| 2020 |
Hawryluk EB, Moustafa D, Bartenstein D, Brahmbhatt M, Cordoro K, Gardner L, Gauthier A, Grossman D, Gupta D, Hunt RD, Jen M, Kao PC, Kruse LL, Lawley LP, London WB, et al. A Retrospective Multicenter Study of Fatal Pediatric Melanoma. Journal of the American Academy of Dermatology. PMID 32622142 DOI: 10.1016/J.Jaad.2020.06.1010 |
0.345 |
|
| 2020 |
Rahman H, Kumar D, Liu T, Okwundu N, Lum D, Florell SR, Burd CE, Boucher KM, VanBrocklin MW, Grossman D. Aspirin protects melanocytes and keratinocytes against UVB-induced DNA damage in vivo. The Journal of Investigative Dermatology. PMID 32569596 DOI: 10.1016/J.Jid.2020.06.003 |
0.352 |
|
| 2020 |
Hyde MA, Grossman D, Wu YP, Buys S, Gren LH, Hashibe M. Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients. Jaapa : Official Journal of the American Academy of Physician Assistants. 33: 35-41. PMID 32452960 DOI: 10.1097/01.Jaa.0000662388.18867.42 |
0.308 |
|
| 2020 |
Flint ND, Bishop MD, Smart TC, Strunck JL, Boucher KM, Grossman D, Secrest AM. Low accuracy of self-reported family history of melanoma in high-risk patients. Familial Cancer. PMID 32436000 DOI: 10.1007/S10689-020-00187-0 |
0.321 |
|
| 2020 |
Strunck JL, Smart TC, Boucher KM, Secrest AM, Grossman D. Improved melanoma outcomes and survival in patients monitored by total body photography: A natural experiment. The Journal of Dermatology. PMID 31953873 DOI: 10.1111/1346-8138.15221 |
0.303 |
|
| 2019 |
Shah A, Hyngstrom J, Florell SR, Grossman D. Use of the Pigmented Lesion Assay to rapidly screen a patient with numerous clinically atypical pigmented lesions. Jaad Case Reports. 5: 1048-1050. PMID 31768410 DOI: 10.1016/J.Jdcr.2019.10.004 |
0.328 |
|
| 2019 |
Grossman D, Florell SR, Duffy KL, Bowen GM. Histologic criteria for assessing surgical margins in melanoma in situ. Journal of the American Academy of Dermatology. PMID 31751588 DOI: 10.1016/J.Jaad.2019.10.080 |
0.304 |
|
| 2019 |
Li C, Liu T, Tavtigian SV, Boucher K, Kohlmann W, Cannon-Albright L, Grossman D. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants. Melanoma Research. PMID 31567591 DOI: 10.1097/Cmr.0000000000000645 |
0.324 |
|
| 2019 |
Varedi A, Gardner LJ, Kim CC, Chu EY, Ming ME, Leachman SA, Curiel-Lewandrowski C, Swetter SM, Grossman D. Use of new molecular tests for melanoma by pigmented lesion experts. Journal of the American Academy of Dermatology. PMID 31415835 DOI: 10.1016/J.Jaad.2019.08.022 |
0.302 |
|
| 2019 |
Li C, Liu T, Liu B, Hernandez R, Facelli JC, Grossman D. A novel CDKN2A variant (p16 ) in a patient with familial and multiple primary melanomas. Pigment Cell & Melanoma Research. PMID 31001908 DOI: 10.1111/Pcmr.12787 |
0.354 |
|
| 2019 |
Gardner LJ, Strunck JL, Wu YP, Grossman D. Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression. Journal of the American Academy of Dermatology. 80: 1-12. PMID 30553298 DOI: 10.1016/J.Jaad.2018.03.053 |
0.375 |
|
| 2018 |
Truong A, Hyngstrom JR, Andtbacka RHI, Noyes RD, Wright M, Snyder J, Winters A, Sause WT, Grossmann KF, Khong HT, Bowen GM, Hitchcock YJ, Grossman D, Bowles TL. Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status. Melanoma Research. PMID 31219456 DOI: 10.1097/Cmr.0000000000000534 |
0.305 |
|
| 2018 |
Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, et al. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. Jama Dermatology. PMID 30304348 DOI: 10.1001/Jamadermatol.2018.3359 |
0.314 |
|
| 2018 |
Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, ... ... Grossman D, et al. Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials. Cancer. PMID 30281145 DOI: 10.1002/Cncr.31719 |
0.322 |
|
| 2018 |
Grossman D, Kumar D, Rahman H, Tyagi E, Liu T, Li C, Lu R, Lum D, Holmen SL, Maschek JA, Cox JE, VanBrocklin MW. Aspirin suppresses PGE and activates AMP kinase to inhibit melanoma cell motility, pigmentation and selective tumor growth . Cancer Prevention Research (Philadelphia, Pa.). PMID 30021726 DOI: 10.1158/1940-6207.Capr-18-0087 |
0.382 |
|
| 2018 |
Teerlink CC, Huff C, Stevens J, Yu Y, Holmen SL, Silvis MR, Trombetti K, Zhao H, Grossman D, Farnham JM, Wen J, Facelli JC, Thomas A, Babst M, Florell SR, et al. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. Journal of the National Cancer Institute. PMID 29659923 DOI: 10.1093/Jnci/Djy058 |
0.307 |
|
| 2018 |
Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA. Similar survival of patients with multiple vs. single primary melanomas based on Utah SEER data (1973-2011). Journal of the American Academy of Dermatology. PMID 29499295 DOI: 10.1016/J.Jaad.2018.02.055 |
0.318 |
|
| 2018 |
Kumar D, Rahman H, Grossman D. 1206 Aspirin inhibits melanoma cell motility through suppression of PGE2 and activation of AMPK Journal of Investigative Dermatology. 138: S205. DOI: 10.1016/J.Jid.2018.03.1221 |
0.334 |
|
| 2017 |
Robinson JP, Rebecca VW, Kircher DA, Silvis MR, Smalley I, Gibney GT, Lastwika KJ, Chen G, Davies MA, Grossman D, Smalley KSM, Holmen SL, VanBrocklin MW. Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. Melanoma Research. 27: 545-557. PMID 29076949 DOI: 10.1097/Cmr.0000000000000403 |
0.331 |
|
| 2017 |
Gardner LJ, Ward M, Andtbacka RHI, Boucher KM, Bowen GM, Bowles TL, Cohen AL, Grossmann K, Hitchcock YJ, Holmen SL, Hyngstrom J, Khong H, McMahon M, Monroe MM, Ross CB, ... ... Grossman D, et al. Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Melanoma Research. PMID 28800031 DOI: 10.1097/Cmr.0000000000000382 |
0.344 |
|
| 2017 |
Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, et al. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Management. 4: 13-37. PMID 28758010 DOI: 10.2217/Mmt-2016-0022 |
0.303 |
|
| 2017 |
Parsons BG, Gren LH, Simonsen SE, Harding G, Grossman D, Wu YP. Opportunities for Skin Cancer Prevention Education among Individuals Attending a Community Skin Cancer Screening in a High-Risk Catchment Area. Journal of Community Health. PMID 28752269 DOI: 10.1007/S10900-017-0406-8 |
0.316 |
|
| 2015 |
March J, Hand M, Truong A, Grossman D. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches. Journal of the American Academy of Dermatology. 72: 943-58; quiz 959-60. PMID 25980999 DOI: 10.1016/J.Jaad.2015.02.1140 |
0.352 |
|
| 2015 |
March J, Hand M, Grossman D. Practical application of new technologies for melanoma diagnosis: Part I. Noninvasive approaches Journal of the American Academy of Dermatology. 72: 929-941. PMID 25980998 DOI: 10.1016/J.Jaad.2015.02.1138 |
0.356 |
|
| 2015 |
Soltani-Arabshahi R, Sweeney C, Jones B, Florell SR, Hu N, Grossman D. Predictive value of biopsy specimens suspicious for melanoma: support for 6-mm criterion in the ABCD rule. Journal of the American Academy of Dermatology. 72: 412-8. PMID 25582536 DOI: 10.1016/J.Jaad.2014.11.030 |
0.362 |
|
| 2015 |
Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. Jama Dermatology. 151: 212-8. PMID 25409291 DOI: 10.1001/Jamadermatol.2014.2694 |
0.303 |
|
| 2015 |
Bowen RC, Meek S, Williams M, Grossmann KF, Andtbacka RHI, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Holmen SL, VanBrocklin MW, Khong HT. A phase I study of intratumoral injection of ipilimumab and interleukin-2 in patients with unresectable stage III-IV melanoma. Journal of Clinical Oncology. 33: 3018-3018. DOI: 10.1200/Jco.2015.33.15_Suppl.3018 |
0.312 |
|
| 2014 |
Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D. Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. Journal of the American Academy of Dermatology. 71: 835-8. PMID 25219711 DOI: 10.1016/J.Jaad.2014.06.044 |
0.335 |
|
| 2014 |
Malvehy J, Hauschild A, Curiel-Lewandrowski C, Mohr P, Hofmann-Wellenhof R, Motley R, Berking C, Grossman D, Paoli J, Loquai C, Olah J, Reinhold U, Wenger H, Dirschka T, Davis S, et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety. The British Journal of Dermatology. 171: 1099-107. PMID 24841846 DOI: 10.1111/Bjd.13121 |
0.374 |
|
| 2014 |
Goodman JR, Grossman D. Aspirin and other NSAIDs as chemoprevention agents in melanoma. Cancer Prevention Research (Philadelphia, Pa.). 7: 557-64. PMID 24694780 DOI: 10.1158/1940-6207.Capr-14-0018 |
0.355 |
|
| 2013 |
McKenzie JA, Liu T, Jung JY, Jones BB, Ekiz HA, Welm AL, Grossman D. Survivin promotion of melanoma metastasis requires upregulation of α5 integrin Carcinogenesis. 34: 2137-2144. PMID 23640047 DOI: 10.1093/Carcin/Bgt155 |
0.702 |
|
| 2013 |
Jenkins NC, Grossman D. Role of melanin in melanocyte dysregulation of reactive oxygen species Biomed Research International. 2013. PMID 23555101 DOI: 10.1155/2013/908797 |
0.315 |
|
| 2013 |
Grossman D, Bowen GM. Commentary: Transecting melanomas: Does it matter? Dermatologic Surgery. 39: 616-617. PMID 23551555 DOI: 10.1111/Dsu.12132 |
0.31 |
|
| 2013 |
Cassidy PB, Fain HD, Cassidy JP, Tran SM, Moos PJ, Boucher KM, Gerads R, Florell SR, Grossman D, Leachman SA. Selenium for the prevention of cutaneous melanoma. Nutrients. 5: 725-49. PMID 23470450 DOI: 10.3390/Nu5030725 |
0.408 |
|
| 2013 |
Jenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D. Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions. The Journal of Investigative Dermatology. 133: 1043-51. PMID 23190892 DOI: 10.1038/Jid.2012.401 |
0.3 |
|
| 2012 |
Grossman D, Duffy KL, Bowen GM. Surgical margins for melanoma in situ. Journal of the American Academy of Dermatology. 67: 1068-9; author reply. PMID 23062889 DOI: 10.1016/J.Jaad.2012.04.046 |
0.306 |
|
| 2012 |
Mckenzie JA, Grossman D. Role of the apoptotic and mitotic regulator survivin in melanoma Anticancer Research. 32: 397-404. PMID 22287725 |
0.698 |
|
| 2012 |
Leachman SA, Smalley KSM, Grossman D, Bowen GM, Messina JL, Berwick M, Glass LF, Swetter SM, Sondak VK. Joint melanoma meetings in Tampa enhance communication and collaboration Expert Review of Dermatology. 7: 129-131. DOI: 10.1586/Edm.12.12 |
0.374 |
|
| 2011 |
Goodson AG, Florell SR, Boucher KM, Grossman D. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 37: 1620-30. PMID 21790849 DOI: 10.1111/J.1524-4725.2011.02097.X |
0.332 |
|
| 2011 |
Grossman D. Failure to compare dermoscopy findings of pigmented lesions on your patient: Comment on "Dermoscopy of patients with multiple nevi". Archives of Dermatology. 147: 50. PMID 21242393 DOI: 10.1001/Archdermatol.2010.390 |
0.324 |
|
| 2011 |
Jenkins NC, Liu T, Cassidy P, Leachman SA, Boucher KM, Goodson AG, Samadashwily G, Grossman D. The p16(INK4A) tumor suppressor regulates cellular oxidative stress. Oncogene. 30: 265-74. PMID 20838381 DOI: 10.1038/Onc.2010.419 |
0.327 |
|
| 2010 |
McKenzie JA, Liu T, Goodson AG, Grossman D. Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation Cancer Research. 70: 7927-7937. PMID 20807805 DOI: 10.1158/0008-5472.Can-10-0194 |
0.698 |
|
| 2010 |
Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 36: 1087-98. PMID 20653722 DOI: 10.1111/J.1524-4725.2010.01589.X |
0.333 |
|
| 2010 |
Jenkins N, Liu T, Goodson A, Samadashwily G, Grossman D. Abstract 4390: The p16INK4Atumor suppressor regulates cellular oxidative stress Cancer Research. 70: 4390-4390. DOI: 10.1158/1538-7445.Am10-4390 |
0.353 |
|
| 2009 |
Goodson AG, Grossman D. Strategies for early melanoma detection: Approaches to the patient with nevi. Journal of the American Academy of Dermatology. 60: 719-35; quiz 736-8. PMID 19389517 DOI: 10.1016/J.Jaad.2008.10.065 |
0.35 |
|
| 2009 |
LaBarbera DV, Modzelewska K, Glazar AI, Gray PD, Kaur M, Liu T, Grossman D, Harper MK, Kuwada SK, Moghal N, Ireland CM. The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells. Anti-Cancer Drugs. 20: 425-36. PMID 19369860 DOI: 10.1097/Cad.0B013E32832Ae55F |
0.356 |
|
| 2008 |
Raj D, Liu T, Samadashwily G, Li F, Grossman D. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis. 29: 194-201. PMID 17916908 DOI: 10.1093/Carcin/Bgm219 |
0.348 |
|
| 2007 |
Fuller SR, Bowen GM, Tanner B, Florell SR, Grossman D. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 33: 1198-206; discussion. PMID 17903152 DOI: 10.1111/J.1524-4725.2007.33254.X |
0.359 |
|
| 2007 |
Thomas J, Liu T, Cotter MA, Florell SR, Robinette K, Hanks AN, Grossman D. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Research. 67: 5172-8. PMID 17545596 DOI: 10.1158/0008-5472.Can-06-3669 |
0.368 |
|
| 2006 |
Yan H, Brouha B, Liu T, Raj D, Biddle D, Lee R, Grossman D. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase. Journal of Dermatological Science. 43: 189-200. PMID 16806840 DOI: 10.1016/J.Jdermsci.2006.05.007 |
0.323 |
|
| 2006 |
Liu T, Biddle D, Hanks AN, Brouha B, Yan H, Lee RM, Leachman SA, Grossman D. Activation of dual apoptotic pathways in human melanocytes and protection by survivin. The Journal of Investigative Dermatology. 126: 2247-56. PMID 16728972 DOI: 10.1038/Sj.Jid.5700381 |
0.318 |
|
| 2006 |
Yan H, Thomas J, Liu T, Raj D, London N, Tandeski T, Leachman S, Lee RM, Grossman D. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist Oncogene. 25: 6968-6974. PMID 16702945 DOI: 10.1038/Sj.Onc.1209676 |
0.369 |
|
| 2006 |
Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. The Journal of Investigative Dermatology. 126: 243-57. PMID 16418733 DOI: 10.1038/Sj.Jid.5700008 |
0.354 |
|
| 2005 |
Wheeler RH, Jones D, Sharma P, Davis RK, Spilker H, Boucher K, Leachman S, Grossman D, Salzman K, Akerley W. Clinical and molecular phase II study of gefitinib in patients (pts) with recurrent squamous cell cancer of the head and neck (H&N Ca). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5531. PMID 27945278 DOI: 10.1200/Jco.2005.23.16_Suppl.5531 |
0.303 |
|
| 2005 |
Florell SR, Bowen AR, Hanks AN, Murphy KJ, Grossman D. Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi. Journal of Cutaneous Pathology. 32: 45-9. PMID 15660660 DOI: 10.1111/J.0303-6987.2005.00242.X |
0.388 |
|
| 2005 |
Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D. UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis. 26: 249-57. PMID 15498793 DOI: 10.1093/Carcin/Bgh300 |
0.371 |
|
| 2004 |
Bowen AR, Hanks AN, Murphy KJ, Florell SR, Grossman D. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. The American Journal of Dermatopathology. 26: 177-81. PMID 15166502 DOI: 10.1097/00000372-200406000-00001 |
0.386 |
|
| 2004 |
Alexander A, Harris RM, Grossman D, Bruggers CS, Leachman SA. Vulvar melanoma: diffuse melanosis and metastasis to the placenta. Journal of the American Academy of Dermatology. 50: 293-8. PMID 14726891 DOI: 10.1016/J.Jaad.2003.07.009 |
0.383 |
|
| 2004 |
Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. Molecular Pharmacology. 65: 18-27. PMID 14722233 DOI: 10.1124/Mol.65.1.18 |
0.308 |
|
| 2004 |
Liu T, Brouha B, Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene. 23: 39-48. PMID 14712209 DOI: 10.1038/Sj.Onc.1206978 |
0.322 |
|
| 2003 |
Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, Noyes RD, Bowen GM, Leachman SA. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2179-86. PMID 12775744 DOI: 10.1200/Jco.2003.12.149 |
0.316 |
|
| 2003 |
Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D. Apoptosis regulators and responses in human melanocytic and keratinocytic cells. The Journal of Investigative Dermatology. 120: 48-55. PMID 12535197 DOI: 10.1046/J.1523-1747.2003.12010.X |
0.369 |
|
| 2002 |
Grossman D, Altieri DC. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Reviews. 20: 3-11. PMID 11831644 DOI: 10.1023/A:1013123532723 |
0.373 |
|
| 2001 |
Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC, Altieri DC. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. Journal of Clinical Investigation. 108: 991-999. PMID 11581300 DOI: 10.1172/Jci13345 |
0.355 |
|
| 2001 |
Grossman D, Kim PJ, Schechner JS, Altieri DC. Inhibition of melanoma tumor growth in vivo by survivin targeting Proceedings of the National Academy of Sciences of the United States of America. 98: 635-640. DOI: 10.1073/Pnas.98.2.635 |
0.385 |
|
| 2000 |
O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC, Altieri DC. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proceedings of the National Academy of Sciences of the United States of America. 97: 13103-13107. PMID 11069302 DOI: 10.1073/Pnas.240390697 |
0.313 |
|
| 1999 |
Grossman D, McNiff JM, Li F, Altieri DC. Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma Journal of Investigative Dermatology. 113: 1076-1081. PMID 10594755 DOI: 10.1046/J.1523-1747.1999.00776.X |
0.428 |
|
| 1999 |
Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. The New England Journal of Medicine. 341: 452-453. PMID 10438269 DOI: 10.1056/Nejm199908053410614 |
0.32 |
|
| 1997 |
Grossman D, Leffell DJ. The Molecular Basis of Nonmelanoma Skin Cancer: New Understanding Archives of Dermatology. 133: 1263-1270. DOI: 10.1001/Archderm.1997.03890460087010 |
0.371 |
|
| 1994 |
Grossman D, Rapini RP, Osborne B, Duvic M. Emergence of leprosy in a patient with mycosis fungoides Journal of the American Academy of Dermatology. 30: 313-315. PMID 8294589 DOI: 10.1016/S0190-9622(94)70030-3 |
0.323 |
|
| Show low-probability matches. |